Abstract
In cardiac failure, arterial underfilling leads to neurohumeral activation and renal sodium and water retention, thus increasing both the preload and afterload, potentially setting up a vicious cycle leading to a cardiorenal syndrome. During acute decompensated heart failure, a deterioration in renal function is associated with a markedly increased risk of patient mortality.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Anand IS, Kuskowski MA, Rector TS et al. (2005) Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Circulation 112:1121–1127.
Chen HH, Schrier RW (2006) Pathophysiology of volume overload in acute heart failure syndromes. Am J Med 119:S11–S16.
Costanzo MR, Guglin ME, Saltzberg et al. (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675–683.
Forman DE, Butler J, Wang Y et al. (2004) Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67.
Funabiki K, Masuoka H, Shimizu H et al. (2003) Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. Jpn Heart J 44:767–774.
Gheorghiade M, Niazi I, Ouyang J et al. (2003) Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 107:2690–2696.
Goldsmith SR (2006) Is there a cardiovascular rationale for the use of combined vasopressin V1a/V2 receptor antagonists? Am J Med 119(Suppl 1):S93–S96.
Gottlieb SS, Brater DC, Thomas I et al. (2002) BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348–1353.
Felker GM, Adams KF Jr, Konstam MA et al. (2003) The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J 145(Suppl 2):S18–25.
Heywood JT, Fonarow GC, Costanzo MR et al. (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13:422–430.
Iglesias J, Hom D, Antoniotti M et al. (2006) Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). Nephrol Dial Transplant 21:3458–3465.
Januzzi JL Jr, Camargo A, Anwarruddin S et al. (2005) The N terminal pro-BNP investigation of dyspnoea in the emergency department (PRIDE) study. Am J Cardiol 95: 1625–1633.
Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018.
Juurlink DN, Mamdani MM, Lee DS et al. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 351:543–551.
Kalra P, Guo H, Kausz AT et al. (2005) Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kid Int 62:293–301.
Kingdon EJ, Holt SG, Davar J et al. (2001) Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis 38: 631–639.
Krumholz HM, Chen Y-T, Vaccarino V et al. (2000) Correlates and impacts on outcomes of worsening renal function in patients ≥ 65 years of age with heart failure. Am J Cardiol 139:72–77.
Libetta C, Sepe V, Zucchi M et al. (2007) Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol Dial Transplant 22:2013–2019.
Maisel AS, Krishnaswamy P, Nowak RM et al. (2002) Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167.
Maisel AS, Krishnaswamy P, Nowak RM et al. (2004) BNP Multinational Study Investigators. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J 147:1078–1084.
Palmer BF (2002) Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347:1256–1261.
Saltzman HE, Sharma K, Mather PJ et al. (2007) Renal dysfunction in heart failure patients: what is the evidence ? Heart Fail Rev 12:37–47.
Schrier RW (2007) Cardiorenal versus renocardiac syndrome: is there a difference? Nat Clin Pract Nephrol. 3:637.
Takahashi T, Konta T, Nishida W et al. (2003) Renal cholesterol embolic disease effectively treated with steroid pulse therapy. Intern Med 42:1206–1209.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Davenport, A. (2010). Acute Kidney Problems in Congestive Heart Failure. In: Jörres, A., Ronco, C., Kellum, J. (eds) Management of Acute Kidney Problems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-540-69441-0_30
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69413-7
Online ISBN: 978-3-540-69441-0
eBook Packages: MedicineMedicine (R0)